GlaxoSmithKline Consumer Healthcare Announces the Return of alli® to Retail Stores
GlaxoSmithKline Recalls alli®
GSK Reports alli® Product Tampering, Alerts Consumers to Unknown Product in alli® Packages
GSK Consumer Healthcare To Update alli® Label As FDA Completes Safety Review Of Orlistat
alli® Proven to Reduce Visceral Fat, a Dangerous Fat Linked to Many Life-threatening Diseases, According to New Data Released Today
NEED MORE INFO?
SIGN UP FOR alli®
UPDATES & OFFERS
CONNECT WITH US
© 2015 GSK group of companies or its licensor. All Rights Reserved. This site is intended for U.S. residents only. alli, myalliplan, Shuttle, the Shuttle Carry Case, and other designs are trademarks owned by or licensed to the GSK group of companies. alli® (orlistat 60mg capsules) is for weight loss in overweight adults, 18 years and older, when used along with a reduced-calorie and low-fat diet. Follow label directions.